(Total Views: 376)
Posted On: 02/12/2025 10:10:15 AM
Post# of 154722
The gut microbiome which can increase CCL2 and TFN-a has also been associated with various ailments involved in inflammation. Anti-TFN-a drugs have been used in bowel diseases and decrease TFN-a inducing bacteria. Leronlimab should help do the same.
(6)
(0)
